NCL are the most common neurometabolic neurodegenerative disease with an estimated prevalence of 1.5 to 9 per million population.1, 2 The most prevalent NCL are CLN3 disease (MIM#204200) and CLN2 (TPP1) disease (MIM#204500). This evidence concerns the gene CLN3 and neuronal ceroid lipofuscinosis.